No Data
No Data
Owning 32% Shares,institutional Owners Seem Interested in ProKidney Corp. (NASDAQ:PROK),
Cautiously Optimistic: ProKidney's Hold Rating Amid Accelerated Pathway and Trial Developments
ProKidney to Present at the 43rd Annual J.P. Morgan Healthcare Conference
One ProKidney Insider Raised Their Stake In The Previous Year
ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference
ProKidney (NASDAQ:PROK) Is In A Good Position To Deliver On Growth Plans